Copyright
©The Author(s) 2004.
World J Gastroenterol. Jan 1, 2004; 10(1): 136-142
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.136
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.136
Figure 4 Changes in CD57+ cell percentages in perioperative period.
A: at randomization; B: before operation; C: on the 2nd postoperative day; and D: on the 10th postoperative day. The difference in CD57+ percentages between treatment and con-trol groups at time points C and D was statistically significant, bP < 0.01. The differences in CD57+ percentages between treat-ment group and normal control on the 10th postoperative day was statistically significant, dP < 0.01.
- Citation: Lin CY, Bai DJ, Yuan HY, Wang K, Yang GL, Hu MB, Wu ZQ, Li Y. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial. World J Gastroenterol 2004; 10(1): 136-142
- URL: https://www.wjgnet.com/1007-9327/full/v10/i1/136.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i1.136